If I may add to your response pogues
Margaret, your response that Hopper wants Annagralide is of concern to me, but I think it is an entirely reasonable assumption.
So, I would like him to address the market about our other stuff given that we have only done one co-development deal on the Hydrotope platform and one option, remember all the Zolpimist deals are done on the old platform.
This is to me is our greatest mystery (misery) and is either a reflection of our sales staff or the product.
Clyde
Ann: Operational Update, page-65
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
0.005(3.70%) |
Mkt cap ! $147.2M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 14.5¢ | 13.5¢ | $174.0K | 1.245M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 61995 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 183155 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| ALA (ASX) Chart |